More tools:Markets·Screener·Research·Chat

Invivyd, Inc. Common Stock (IVVD) Financial Statements

Invivyd, Inc. Common Stock
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG00W4ML048
XNAS · usd
0.80▼ 0.03 (-3.45%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA—
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close0.83
Day's Range0.78 – 0.82
52-Week Range0.53 – 3.07
Volume1.9M
Avg Volume3.7M
Share Statistics
Shares Outstanding
Employees122
ExchangeXNAS
Listed2021-08-06
Share count as of July 30, 2026
Loading Income Statement…
Key questions about Invivyd, Inc. Common Stock (IVVD)
What is Invivyd, Inc. Common Stock's Market Cap?
Invivyd, Inc. Common Stock's Market Cap is $235.0M, based on as-reported figures from SEC (XBRL) filings.
What is Invivyd, Inc. Common Stock's Enterprise Value?
Invivyd, Inc. Common Stock's Enterprise Value is $74.9M, based on as-reported figures from SEC (XBRL) filings.
What is Invivyd, Inc. Common Stock's Price / Sales?
Invivyd, Inc. Common Stock's Price / Sales is 4.0×, based on as-reported figures from SEC (XBRL) filings.
What is Invivyd, Inc. Common Stock's EV / Revenue?
Invivyd, Inc. Common Stock's EV / Revenue is 1.3×, based on as-reported figures from SEC (XBRL) filings.
What is Invivyd, Inc. Common Stock's Revenue (TTM)?
Invivyd, Inc. Common Stock's Revenue (TTM) is $58.4M, based on as-reported figures from SEC (XBRL) filings.
What is Invivyd, Inc. Common Stock's Net Income (TTM)?
Invivyd, Inc. Common Stock's Net Income (TTM) is -$107.3M, based on as-reported figures from SEC (XBRL) filings.
What is Invivyd, Inc. Common Stock's Diluted EPS (TTM)?
Invivyd, Inc. Common Stock's Diluted EPS (TTM) is -0.36, based on as-reported figures from SEC (XBRL) filings.
What is Invivyd, Inc. Common Stock's Net Debt?
Invivyd, Inc. Common Stock's Net Debt is -$160.1M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Total revenue—
YoY growth+21.2%—+24.5%+41.2%
Operating costs and expenses:
Cost of product revenue—
Research and development—
Selling, general and administrative—
Total operating costs and expenses—
% of revenue420.8%—173.0%184.0%
Loss from operations—
% of revenue-320.8%—-73.0%-84.0%
Other income:
Other income, net—
Total other income, net—
Net loss
% of revenue-310.8%—-64.3%-79.7%
Net loss per share attributable to common stockholders, basic—
Net loss per share attributable to common stockholders,diluted—